Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will participate in the Morgan Stanley Healthcare Conference on Tuesday, September 13, 2011, at the Grand Hyatt, New York City, beginning at 8:00 a.m. Eastern Time.
Mr. Worthington will provide brief remarks and then the session will transition to a question-and-answer period with the audience, moderated by a Morgan Stanley research analyst.
Audio of the Fluidigm session will be simultaneously webcast at: http://web.servicebureau.net/conf/meta?i=1113263563&c=2343&m=was&u=/w2.xsl or http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=221384&eventID=4197242.
The webcast will be archived for 90 days following the live presentation.
About Fluidigm
Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including chips and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems, including eight different commercial chips, to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.
For more information, please visit www.fluidigm.com.
“Fluidigm” and the Fluidigm logo are trademarks or registered trademarks of Fluidigm.
Contacts:
Howard High, 650-266-6081 (office)
or
510-786-7378 (mobile)
howard.high@fluidigm.com
